Neurodegeneration and inflammation in Parkinson's disease.
about
Neuroplasticity and the next wave of antidepressant strategiesChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesSex differences in Parkinson's diseaseFriend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingFBXO7 Y52C polymorphism as a potential protective factor in Parkinson's diseaseHistamine: a new immunomodulatory player in the neuron-glia crosstalk.Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agentsEarly immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Eryptosis as a marker of Parkinson's diseaseMolecular mechanisms underlying the effects of statins in the central nervous system.Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamineRotenone directly induces BV2 cell activation via the p38 MAPK pathway.Biological evaluation of synthetic chalcone and flavone derivatives as anti-inflammatory agentsA novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis.Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations.Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease modelsSomatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial CellsNatural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.Measurement of Voluntary Cough Production and Airway Protection in Parkinson DiseaseCurcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP(+))-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathwayGlial-mediated inflammation underlying parkinsonism.Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in MiceHMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell ModelNADPH oxidase-derived H2O2 mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease.6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation.Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.Advances in non-dopaminergic treatments for Parkinson's diseaseDevelopments and new vistas in the field of melanocortins.Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients.Parkinson's disease managing reversible neurodegeneration.MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity.Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease.
P2860
Q21129480-D0B68243-D13C-40DE-B7F0-977BCDDA4295Q26748974-18B60243-ABBA-4501-A750-6EBD5B348B00Q26767289-15E0CF4E-8B97-4859-80B6-99F3DFDFAB1DQ27025107-5E19F0CA-AE4A-432D-B868-2C7D6B9A967CQ28077869-25EE6C34-A7A7-4A73-B1F8-63E6AF392E44Q28118464-32F323B5-37F2-49F9-885B-D6FC71BFFF72Q33574684-17D9ED6E-4D34-409E-AFD0-9C9EE7040E6EQ33703744-AFA461EF-3E5A-41F4-AC5F-60332B4FBEA6Q33719355-9D8C5859-8A61-4BCB-8EC5-D1421EFD8BEBQ34195302-C94F6EF5-4509-4791-9A4D-3CA5E73CCA88Q34585744-1DD503D7-5E21-42DF-AAF3-227B6C371A34Q34685463-0D98937F-3EE1-4F28-9F8B-9C6AB42EB6B1Q34936413-315F3BB0-1ACA-4288-8E09-E53AA4D342B2Q34972939-09385886-8212-4225-9653-28CBCEEF1E35Q35322839-0F89B8B4-C60D-48DE-B83D-20B2DA2F221AQ35514746-5F09D30A-C05A-483F-A17D-D68002478E4DQ35515556-C313BA74-5A76-4AA5-B978-44EC95FB9079Q35529695-6EF9442E-40BE-4B25-A60B-898B4B57129AQ35628403-D9B3EC96-23B8-4757-B931-FC9CB98F6088Q35632000-5C5452EA-601E-481B-B267-B890FC7A2C7BQ35808114-BC3B14E5-E295-4F29-AE20-02169D7F3B4DQ35822089-B17F2EC9-11A4-45A0-82F9-63A48DB0DA05Q35838808-C719CD08-B2F8-47F3-98E5-9BEFF3FDB6E5Q36626869-1BA40C1D-94E9-48B5-9A9B-0F0255C0C0EDQ37004610-224A97D5-29B3-42A1-AB8A-B71E9E2645F4Q37287778-9ED38008-1D1F-46DE-877D-2CCB8F6C4CEFQ37334985-F89D20CA-DA34-4CD6-AE5A-23E37F6ADFDBQ37614664-95D967D3-BECC-475A-8146-AB5427CD19FFQ37670116-1787B6C3-A7B5-4B6C-A701-793A80CD300FQ37729570-02850686-024E-40A7-9C7F-D7A1F2B11B87Q38151947-7E795C07-7F33-49AA-8C99-EAFA94EEA259Q38198015-B624E93C-1282-403E-B214-DA8610349846Q38218083-9599C6E8-B6F0-4EA4-8EEE-B896FBFB2850Q38610760-E55607F3-D689-4601-8CD6-9C2968432039Q38674162-2BED670E-FFB2-40A3-B4E5-06ABDA6CBC20Q39375357-FED9BB5D-BA28-441B-9C14-A346CE9F511EQ40030359-E1A0CF0C-D8FE-4FAA-B028-273FD6300B62Q42446212-6ACF3CE6-F9F7-4E71-967B-25606D613525Q42739828-22A360CA-618A-4C16-8A7C-10FAC79BC16DQ42839842-1E382684-B8E9-4BB2-82ED-1012A62D24F6
P2860
Neurodegeneration and inflammation in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neurodegeneration and inflammation in Parkinson's disease.
@en
Neurodegeneration and inflammation in Parkinson's disease.
@nl
type
label
Neurodegeneration and inflammation in Parkinson's disease.
@en
Neurodegeneration and inflammation in Parkinson's disease.
@nl
prefLabel
Neurodegeneration and inflammation in Parkinson's disease.
@en
Neurodegeneration and inflammation in Parkinson's disease.
@nl
P1476
Neurodegeneration and inflammation in Parkinson's disease.
@en
P2093
John D Loike
Sudarshan Phani
P304
P356
10.1016/S1353-8020(11)70064-5
P478
18 Suppl 1
P577
2012-01-01T00:00:00Z